Clinical Trial Update: Early Metabolic Support as a Potential Solution to Multi-Organ Dysfunction Syndrome (MODS) During Severe Sepsis [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating early metabolic support for treating multi-organ dysfunction in severe sepsis has been withdrawn from the registry.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Septic Shock

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Septic Shock | Phase 2 | Status: WITHDRAWN